Meriam Kabbaj
Direttore Tecnico/Scientifico/R&S presso GENFIT
Posizioni attive di Meriam Kabbaj
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GENFIT | Direttore Tecnico/Scientifico/R&S | 01/12/2022 | - |
Versantis AG
 Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Direttore/Membro del Consiglio | 01/01/2015 | - |
| Direttore operativo | 01/01/2015 | - | |
| Fondatore | 01/01/2015 | - |
Storia della carriera di Meriam Kabbaj
Formazione di Meriam Kabbaj
| University of Montréal | Doctorate Degree |
Statistiche
Distribuzione geografica
| Canada | 2 |
| Svizzera | 2 |
| Francia | 2 |
Posizioni
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENFIT | Health Technology |
| Aziende private | 1 |
|---|---|
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Meriam Kabbaj
- Esperienza
